Streetbeat News

Products Services

AMRX

Amneal Pharmaceuticals has announced that JAMA Neurology has published the results of a Phase 3 study comparing IPX203 to immediate-release Carbidopa/Levodopa for Parkinson's disease. The study found that IPX203 demonstrated a statistically significant improvement in daily 'Good Time'.

Portfolio Pulse from Benzinga Newsdesk

August 24, 2023 | 8:04 pm

MULN

Mullen Automotive, Inc. (NASDAQ:MULN) has started production of its Class 3 electric vehicles (EVs) and held a launch event at its Tunica facility. The company plans to gradually increase its production rate throughout the year, aiming for a capacity of 3,000 vehicles annually per shift. Mullen also plans to add a second shift for Class 3 production, doubling the capacity to 6,000 vehicles per year. The Mullen THREE, the company's Class 3 EV truck, has a starting price of $68,500 and qualifies for $7,500 in federal tax incentives.

Portfolio Pulse from Happy Mohamed

August 24, 2023 | 7:38 pm

GHRS

GH Research PLC (NASDAQ:GHRS) reported its Q2 2023 financial results, revealing a cash and cash equivalents of $96.9 million, down from $166 million in Dec 2022. However, the company's total liquidity, including other financial assets and marketable securities, stands at $238.1 million, which it believes will cover operating expenses and capital expenditure requirements until 2026. The company reported a quarterly net loss of $7.7 million, compared to a net profit of $334,000 in the same quarter in 2022. GH Research is developing novel 5-MeO-DMT therapies for Treatment-Resistant Depression (TRD) and is currently conducting several clinical trials.

Portfolio Pulse from Lara Goldstein

August 24, 2023 | 7:03 pm

EXEL

NVS

Exelixis Inc's (EXEL) phase 3 CABINET pivotal trial for its lead cancer treatment, Cabometyx, has been recommended to stop early due to significant improvement in efficacy. The trial was evaluating Cabometyx against a placebo in patients with advanced pancreatic neuroendocrine tumors. William Blair analysts have reiterated their Outperform rating for EXEL, despite uncertainties surrounding the market exclusivity of Cabometyx, which is projected until 2030.

Portfolio Pulse from Vandana Singh

August 24, 2023 | 6:46 pm

HOWL

Wedbush analysts initiated coverage on Werewolf Therapeutics Inc (NASDAQ:HOWL) with an Outperform rating and a price target of $9. They believe the company's INDUKINE technology, which leverages its proprietary PREDATOR platform for solid tumors, is underappreciated by the market. The analysts see an attractive risk/reward ahead of initial clinical data from lead asset WTX-124, currently in Phase 1 study, in 4Q 2023. As of June 30, 2023, the company had cash and cash equivalents of $137.5 million.

Portfolio Pulse from Vandana Singh

August 24, 2023 | 6:43 pm

FUV

Arcimoto has reported the production of 94 new Fun Utility Vehicles (FUVs) during the first half of 2023, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

August 24, 2023 | 6:43 pm

NVDA

PLTR

Shares of Palantir Technologies Inc (NYSE:PLTR) are trading lower by approximately 6.37% amid broader tech sector weakness. The company's shares initially traded higher in sympathy with NVIDIA, which reported strong Q2 financial results and Q3 guidance. Palantir, known for its AI-driven data analytics platforms, could potentially benefit from NVIDIA's robust AI performance. NVIDIA's success might indicate improved data analytics capabilities, leading to increased demand for Palantir's platforms and services.

Portfolio Pulse from Henry Khederian

August 24, 2023 | 6:31 pm

TOL

Toll Brothers, a luxury home construction company, has announced a new luxury townhome community in Malvern, Pennsylvania. The project is expected to boost the company's portfolio and revenue in the coming quarters.

Portfolio Pulse from Benzinga Newsdesk

August 24, 2023 | 6:02 pm

AAPL

AMZN

DBX

GOOG

GOOGL

Dropbox Inc (DBX) has announced a policy change to limit its storage to 5 terabytes for its top-tier plans, citing excessive resource use by a minority of users. This follows similar moves by Google (GOOG, GOOGL), Apple (AAPL), and Amazon (AMZN). Dropbox will charge users $8 for each additional terabyte, a shift from their previous unlimited plan priced at $24 monthly. The company reported Q2 earnings of 51 cents per share, beating the consensus of 45 cents, and quarterly sales of $622.50 million, up by 8.70% YoY.

Portfolio Pulse from Anusuya Lahiri

August 24, 2023 | 5:58 pm